X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALKEM LABORATORIES   ADCOCK INGRAM
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
ADCOCK INGRAM
Jun-14
ALKEM LABORATORIES/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs1,589355-   
Low Rs1,232256-   
Sales per share (Unadj.) Rs417.5105.7-  
Earnings per share (Unadj.) Rs56.3-26.6-  
Cash flow per share (Unadj.) Rs64.7-22.1-  
Dividends per share (Unadj.) Rs12.700-  
Dividend yield (eoy) %0.90-  
Book value per share (Unadj.) Rs292.982.9-  
Shares outstanding (eoy) m119.57168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.42.9 116.8%   
Avg P/E ratio x25.1-11.5 -218.2%  
P/CF ratio (eoy) x21.8-13.9 -157.3%  
Price / Book Value ratio x4.83.7 130.6%  
Dividend payout %22.60-   
Avg Mkt Cap Rs m168,65351,606 326.8%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m9,1713,239 283.2%   
Avg. sales/employee Rs ThNM4,154.7-  
Avg. wages/employee Rs ThNM754.5-  
Avg. net profit/employee Rs ThNM-1,046.9-  
INCOME DATA
Net Sales Rs m49,91517,836 279.9%  
Other income Rs m1,645125 1,317.1%   
Total revenues Rs m51,56117,961 287.1%   
Gross profit Rs m8,482-3,091 -274.4%  
Depreciation Rs m1,006770 130.7%   
Interest Rs m671483 138.8%   
Profit before tax Rs m8,451-4,219 -200.3%   
Minority Interest Rs m-114-12 967.7%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,606264 609.2%   
Profit after tax Rs m6,731-4,494 -149.8%  
Gross profit margin %17.0-17.3 -98.1%  
Effective tax rate %19.0-6.2 -304.1%   
Net profit margin %13.5-25.2 -53.5%  
BALANCE SHEET DATA
Current assets Rs m27,06213,063 207.2%   
Current liabilities Rs m15,3247,350 208.5%   
Net working cap to sales %23.532.0 73.4%  
Current ratio x1.81.8 99.4%  
Inventory Days Days67111 60.0%  
Debtors Days Days41124 33.3%  
Net fixed assets Rs m12,6107,615 165.6%   
Share capital Rs m23983 288.7%   
"Free" reserves Rs m34,4900-   
Net worth Rs m35,02713,999 250.2%   
Long term debt Rs m1,2124,920 24.6%   
Total assets Rs m54,38726,446 205.7%  
Interest coverage x13.6-7.7 -175.9%   
Debt to equity ratio x00.4 9.8%  
Sales to assets ratio x0.90.7 136.1%   
Return on assets %13.6-15.2 -89.7%  
Return on equity %19.2-32.1 -59.9%  
Return on capital %24.9-19.8 -125.5%  
Exports to sales %12.90-   
Imports to sales %3.10-   
Net fx Rs m3,5520-   
CASH FLOW
From Operations Rs m7,2591,522 476.8%  
From Investments Rs m1,864-467 -398.8%  
From Financial Activity Rs m-9,2734,465 -207.7%  
Net Cashflow Rs m-1505,520 -2.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.9 Rs / ZAR

Compare ALKEM LABORATORIES With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare ALKEM LABORATORIES With: CADILA HEALTHCARE  WOCKHARDT LTD.  SHASUN PHARMA  ALEMBIC LTD  ELDER PHARMA  



Today's Market

Weak Finish to the Week; Realty & Metal Stocks Plunge(Closing)

Indian share markets continued to languish in red in the afternoon session as rupee hit its weakest point since early April amid concerns.

Related Views On News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

More Views on News

Most Popular

India's Big and Messy Real Estate Ponzi Scheme, Just Got Messier(Vivek Kaul's Diary)

Sep 11, 2017

The question is, whether real estate buyers are financial creditors or not.

The Recipe to Over 60% Returns in Less Than a Year(The 5 Minute Wrapup)

Sep 9, 2017

Short term crisis in some companies could unveil some great investing opportunities.

Feeling Left Out? Two Opportunities to Make Money in This Market(Daily Profit Hunter)

Sep 13, 2017

Nifty is above 10,000 once again. Have you missed the bus?

Introducing Smart Contrarian: The Blueprint for Big Profits from Small Investments

Sep 18, 2017

Welcome to a bold, new initiative designed for the truly contrarian investor.

How To Link Aadhaar With Your Mutual Fund Investments(Outside View)

Sep 11, 2017

The Government has extended the linking of the unique Aadhaar number to nearly all financial transactions.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Sep 22, 2017 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 8-QTR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS